0001140361-15-012986.txt : 20150323 0001140361-15-012986.hdr.sgml : 20150323 20150323203155 ACCESSION NUMBER: 0001140361-15-012986 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150319 FILED AS OF DATE: 20150323 DATE AS OF CHANGE: 20150323 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OncoMed Pharmaceuticals Inc CENTRAL INDEX KEY: 0001302573 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 383572512 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 800 CHESAPEAKE DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-995-8200 MAIL ADDRESS: STREET 1: 800 CHESAPEAKE DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Patel Sunil CENTRAL INDEX KEY: 0001503062 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35993 FILM NUMBER: 15720299 MAIL ADDRESS: STREET 1: 11085 NORTH TORREY PINES RD., SUITE 300 CITY: LA JOLLA STATE: CA ZIP: 92037 4 1 doc1.xml FORM 4 X0306 4 2015-03-19 0 0001302573 OncoMed Pharmaceuticals Inc OMED 0001503062 Patel Sunil C/O ONCOMED PHARMACEUTICALS, INC. 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 0 1 0 0 See Remarks Common Stock 2015-03-19 4 M 0 3335 3.42 A 23335 D Common Stock 2015-03-19 4 S 0 3335 27.3422 D 20000 D Common Stock 2015-03-20 4 M 0 14665 3.42 A 34665 D Common Stock 2015-03-20 4 S 0 14665 27.8584 D 20000 D Stock Option (Right to Buy) 3.42 2015-03-19 4 M 0 3335 0.00 D 2019-07-30 Common Stock 3335 116260 D Stock Option (Right to Buy) 3.42 2015-03-20 4 M 0 14665 0.00 D 2019-07-30 Common Stock 14665 101595 D Includes 20,000 Restricted Stock Units. Transaction executed in multiple trades at prices ranging from $27.34 to $27.3701 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Transaction executed in multiple trades at prices ranging from $27.66 to $27.99 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. The option is fully vested and exercisable. Chief Financial Officer and Senior Vice President, Corporate Development and Finance /s/ Alicia J. Hager, Attorney-in-Fact for Sunil Patel 2015-03-23